Vyvanse Dose Titration Interval
You should wait 1 week between Vyvanse (lisdexamfetamine) dose increases during the titration phase.
Rationale Based on Evidence
While the FDA label for Vyvanse 1 does not specify exact titration intervals, the established practice guidelines for stimulant medications provide clear direction. The American Academy of Child and Adolescent Psychiatry practice parameter 2 explicitly states that stimulant doses should be increased in weekly increments during the titration phase. This applies to amphetamine-based stimulants like Vyvanse (lisdexamfetamine is a prodrug of dextroamphetamine).
Practical Titration Approach
- Start low: Begin with 30 mg daily (the typical starting dose for adults)
- Assess weekly: Evaluate symptom control and side effects at 7-day intervals
- Increase systematically: If symptom control is inadequate, increase by 10-20 mg increments
- Maintain contact: Weekly phone contact during titration is appropriate to monitor response 2
- Duration: The titration phase typically requires 2-4 weeks total 2
Clinical Trial Evidence
Research studies consistently used weekly dose adjustments. The pivotal adult ADHD trial 3 employed forced-dose titration with weekly increases, demonstrating that this interval allows adequate time to assess both efficacy and tolerability. Studies showed significant improvements beginning at week 1 and continuing through each subsequent week 3.
Important Caveats
Do not rush titration. The weekly interval exists for good reason:
- Vyvanse has a half-life of approximately 10-11 hours for the active metabolite (dextroamphetamine) in adults 1
- Steady-state is achieved within several days, but full clinical response assessment requires a full week of consistent dosing
- Side effects (decreased appetite, insomnia, dry mouth) may emerge or resolve over several days 2, 3
Maximum dose considerations: The approved maximum is 70 mg daily. If this dose doesn't provide adequate symptom control, consider switching medications rather than exceeding the maximum 2.
Monitoring during titration: Assess ADHD symptoms systematically using rating scales and obtain reports from multiple sources (patient, family, workplace if applicable) at each weekly interval 2.